رفتن به محتوا
اکنون

در حال تحولروز 1

NSW September unauthorized-peptide emergency visits

  1. به‌روزرسانی 1 از 1جدیدترینروز 1

    NSW records 1,180 peptide-linked emergency visits amid warnings on online products

    Fifteen months of NSW surveillance show a sharp rise in emergency presentations associated with peptide use. The warning concerns unapproved products—not every peptide medicine.

    تماشا

    نخستین منبعABC listen

    آنچه ابتدا می‌دانستیم

    • 1,180Emergency presentations over fifteen months
    • 5Presentations in July 2025
    • More than 217Presentations in September 2026
    • NSW recorded a sharp rise in emergency presentations associated with peptide use, alongside a ministerial warning about serious harm from unregulated products.

    آنچه آن زمان روشن نبود

    • The surveillance does not identify the products involved, their verified contents, the number of distinct patients or how many suffered lasting injury.

    آنچه گفتیم پیگیری می‌کنیم

    • Product-specific findings, fuller surveillance definitions and patient outcomes would show more clearly what is driving the increase. No date has been announced for the next surveillance release.

چه کسی گزارش کرد

چه کسی گزارش کرد

11 رسانه · 25 منبع · 1 ویدئو

تا این لحظه 4 مورد از 11 مورد گزارش شده بود

چه کسانی درگیرند

چه کسانی درگیرند

سازمان‌ها

  • Ministry of Healthministry in New South Wales, Australia
  • Therapeutic Goods Administrationregulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia

مکان‌ها

  • New South Wales